Feb 25, 2010
BiondVax Pharmaceuticals Ltd. (TASE: BNDK), an Israeli biopharmaceutical company and developer of a Universal Influenza Vaccine, today announced that it has signed a term sheet for a 3 year $7 million standby equity distribution agreement